LBEL - 13537-027-03 - (Ensulizole, Octinoxate, Octisalate, Oxybenzone, and Titanium dioxide)

Alphabetical Index


Drug Information of LBEL

Product NDC: 13537-027
Proprietary Name: LBEL
Non Proprietary Name: Ensulizole, Octinoxate, Octisalate, Oxybenzone, and Titanium dioxide
Active Ingredient(s): .03; .075; .05; .06; .039    g/mL; g/mL; g/mL; g/mL; g/mL & nbsp;   Ensulizole, Octinoxate, Octisalate, Oxybenzone, and Titanium dioxide
Administration Route(s): TOPICAL
Dosage Form(s): LOTION
Coding System: National Drug Codes(NDC)

Labeler Information of LBEL

Product NDC: 13537-027
Labeler Name: Ventura Corporation Ltd.
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20110810

Package Information of LBEL

Package NDC: 13537-027-03
Package Description: 1 BOTTLE in 1 BOX (13537-027-03) > 5 mL in 1 BOTTLE (13537-027-02)

NDC Information of LBEL

NDC Code 13537-027-03
Proprietary Name LBEL
Package Description 1 BOTTLE in 1 BOX (13537-027-03) > 5 mL in 1 BOTTLE (13537-027-02)
Product NDC 13537-027
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Ensulizole, Octinoxate, Octisalate, Oxybenzone, and Titanium dioxide
Dosage Form Name LOTION
Route Name TOPICAL
Start Marketing Date 20110810
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Ventura Corporation Ltd.
Substance Name ENSULIZOLE; OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE
Strength Number .03; .075; .05; .06; .039
Strength Unit g/mL; g/mL; g/mL; g/mL; g/mL
Pharmaceutical Classes

Complete Information of LBEL


General Information